Ventus Therapeutics

OverviewSuggest Edit

Ventus Therapeutics is a company that develops small molecule therapeutics intended to target key innate immune pathways. The company specializes in structure-based drug development to translate structural immunology into a pipeline of novel medicines, enabling medical practitioners to treat autoimmune and autoinflammatory diseases.
TypePrivate
HQMontréal, CA
Websiteventustx.com

Latest Updates

Employees (est.) (Jul 2021)44(+5%)
Cybersecurity ratingBMore

Key People/Management at Ventus Therapeutics

Brendan Bulik-Sullivan

Brendan Bulik-Sullivan

Director
Jerel Davis

Jerel Davis

Director
Zack McNealy

Zack McNealy

Chief Financial Officer
Daniel Koerwer

Daniel Koerwer

Chief Business Officer
Marcelo Bigal

Marcelo Bigal

President and Chief Executive Officer, Director
Show more

Ventus Therapeutics Office Locations

Ventus Therapeutics has offices in Montréal and Waltham
Montréal, CA (HQ)
7150 Rue Frederick Banting, Saint-Laurent
Waltham, MA, US
100 Beaver St #202
Show all (2)

Ventus Therapeutics Financials and Metrics

Summary Metrics

Ventus Therapeutics total Funding

$160 m

Ventus Therapeutics latest funding size

$100 m

Time since last funding

4 months ago

Ventus Therapeutics investors

Ventus Therapeutics's latest funding round in April 2021 was reported to be $100 m. In total, Ventus Therapeutics has raised $160 m
Show all financial metrics

Ventus Therapeutics Cybersecurity Score

Cybersecurity ratingPremium dataset

B

85/100

SecurityScorecard logo

Ventus Therapeutics Online and Social Media Presence

Embed Graph

Ventus Therapeutics News and Updates

Ventus Therapeutics Raises $60M in Series A Funding

Ventus Therapeutics, a Waltham, Mass. and Montreal, Canada-based a biopharmaceutical company, raised $60m in Series A financing. The round was led by founding investor Versant Ventures with participation from GV (formerly Google Ventures).

Ventus Therapeutics Frequently Asked Questions

  • Who are Ventus Therapeutics key executives?

    Ventus Therapeutics's key executives are Brendan Bulik-Sullivan, Jerel Davis and Zack McNealy.

  • How many employees does Ventus Therapeutics have?

    Ventus Therapeutics has 44 employees.

  • Who are Ventus Therapeutics competitors?

    Competitors of Ventus Therapeutics include Corestem, Kangstem Biotech and Sanofi.

  • Where is Ventus Therapeutics headquarters?

    Ventus Therapeutics headquarters is located at 7150 Rue Frederick Banting, Saint-Laurent, Montréal.

  • Where are Ventus Therapeutics offices?

    Ventus Therapeutics has offices in Montréal and Waltham.

  • How many offices does Ventus Therapeutics have?

    Ventus Therapeutics has 2 offices.